INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 174 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $447,340 | -53.3% | 1,149,974 | -46.4% | 0.00% | -50.0% |
| Q2 2023 | $958,778 | -0.8% | 2,147,319 | +82.3% | 0.01% | 0.0% |
| Q1 2023 | $966,043 | -68.4% | 1,178,101 | +27.0% | 0.01% | -80.0% |
| Q4 2019 | $3,061,000 | +107.5% | 927,576 | +134.6% | 0.03% | +42.9% |
| Q1 2019 | $1,475,000 | +47.5% | 395,399 | +58.1% | 0.02% | +16.7% |
| Q4 2018 | $1,000,000 | -20.9% | 250,099 | +9.9% | 0.02% | 0.0% |
| Q3 2018 | $1,265,000 | +532.5% | 227,599 | +345.4% | 0.02% | +500.0% |
| Q2 2018 | $200,000 | -47.6% | 51,100 | -37.1% | 0.00% | -50.0% |
| Q1 2018 | $382,000 | +7.3% | 81,200 | -5.7% | 0.01% | 0.0% |
| Q4 2017 | $356,000 | – | 86,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
| Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
| Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
| Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
| Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
| PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
| Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
| Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
| Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 100,274 | $82 | 0.01% |